BiondVax Pharmaceuticals Price on December 29, 2022
BVXVDelisted Stock | USD 1.35 0.03 2.17% |
If you're considering investing in BiondVax Stock, it is important to understand the factors that can impact its price. As of today, the current price of BiondVax Pharmaceuticals stands at 1.35, as last reported on the 29th of December, with the highest price reaching 1.40 and the lowest price hitting 1.34 during the day. We have found twenty-three technical indicators for BiondVax Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please confirm BiondVax Pharmaceuticals' Standard Deviation of 3.6, mean deviation of 2.62, and Risk Adjusted Performance of (0.13) to double-check if the risk estimate we provide is consistent with the expected return of 0.0%.
BiondVax Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
BiondVax |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
BVXV |
Based on monthly moving average BiondVax Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BiondVax Pharmaceuticals by adding BiondVax Pharmaceuticals to a well-diversified portfolio.
Related Headline
Mineralys Therapeutics, Headline on 9th of February 2023
Mineralys Therapeutics, exotic insider transaction detected by Akkaraju Srinivas
Filed transaction by Mineralys Therapeutics In director. Unconventional Insider trading
BiondVax Pharmaceuticals Valuation on December 29, 2022
It is possible to determine the worth of BiondVax Pharmaceuticals on a given historical date. On December 29, 2022 BiondVax was worth 2.84 at the beginning of the trading date compared to the closed value of 3.1. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of BiondVax Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find BiondVax Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of BiondVax Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against BiondVax Pharmaceuticals' related companies.
Open | High | Low | Close | Volume | |
3.06 | 3.15 | 2.83 | 2.94 | 26,509 | |
12/29/2022 | 2.84 | 3.13 | 2.84 | 3.10 | 14,665 |
3.09 | 3.14 | 2.83 | 2.96 | 31,103 |
Backtest BiondVax Pharmaceuticals | | | BiondVax Pharmaceuticals History | | | BiondVax Pharmaceuticals Valuation | Previous | Next |
BiondVax Pharmaceuticals Trading Date Momentum on December 29, 2022
On December 30 2022 BiondVax Pharmaceuticals was traded for 2.96 at the closing time. The top price for the day was 3.14 and the lowest listed price was 2.83 . The trading volume for the day was 31.1 K. The trading history from December 30, 2022 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 4.52% . The overall trading delta against the current closing price is 3.23% . |
BiondVax Pharmaceuticals Fundamentals Correlations and Trends
By evaluating BiondVax Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among BiondVax Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. BiondVax financial account trend analysis is a perfect complement when working with valuation or volatility modules.About BiondVax Pharmaceuticals Stock history
BiondVax Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for BiondVax is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in BiondVax Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing BiondVax Pharmaceuticals stock prices may prove useful in developing a viable investing in BiondVax Pharmaceuticals
BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and other illnesses in Israel. The company was incorporated in 2003 and is headquartered in Jerusalem, Israel. Biondvax Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 15 people.
BiondVax Pharmaceuticals Stock Technical Analysis
BiondVax Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Price Boundaries
BiondVax Pharmaceuticals Period Price Range
Low | December 29, 2024
| High |
0.00 | 0.00 |
BiondVax Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
BiondVax Pharmaceuticals December 29, 2024 Market Strength
Market strength indicators help investors to evaluate how BiondVax Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading BiondVax Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying BiondVax Pharmaceuticals stock market strength indicators, traders can identify BiondVax Pharmaceuticals entry and exit signals to maximize returns
BiondVax Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for BiondVax Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of BiondVax Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of BiondVax to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.13) | |||
Jensen Alpha | (0.64) | |||
Total Risk Alpha | (0.74) | |||
Treynor Ratio | 4.95 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in BiondVax Stock
If you are still planning to invest in BiondVax Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BiondVax Pharmaceuticals' history and understand the potential risks before investing.
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Stocks Directory Find actively traded stocks across global markets | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Transaction History View history of all your transactions and understand their impact on performance |